Penn Davis McFarland’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,500
Closed -$204K 45
2022
Q2
$204K Hold
6,500
0.04% 43
2022
Q1
$286K Hold
6,500
0.05% 43
2021
Q4
$283K Hold
6,500
0.05% 43
2021
Q3
$203K Hold
6,500
0.04% 44
2021
Q2
$275K Hold
6,500
0.05% 42
2021
Q1
$244K Buy
+6,500
New +$203K 0.05% 43
2020
Q3
Sell
-12,000
Closed -$91K 45
2020
Q2
$91K Hold
12,000
0.02% 45
2020
Q1
$110K Hold
12,000
0.04% 40
2019
Q4
$62K Hold
12,000
0.02% 48
2019
Q3
$70K Sell
12,000
-2,000
-14% -$8.97K 0.02% 42
2019
Q2
$45K Hold
14,000
0.02% 38
2019
Q1
$57K Hold
14,000
0.02% 39
2018
Q4
$89K Sell
14,000
-9,500
-40% -$98.6K 0.03% 37
2018
Q3
$388K Buy
23,500
+9,500
+68% +$161K 0.11% 28
2018
Q2
$234K Buy
+14,000
New +$227K 0.07% 39

Other funds holding ACH

Penn Davis McFarland's ACH Position: Q3 2022 in Review

Penn Davis McFarland sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 6,500 shares — an estimated $204K sold.

Penn Davis McFarland first reported a position in ACH in Q2 2018 and held it in 15 quarters. The position peaked at $388K in Q3 2018. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Penn Davis McFarland reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Penn Davis McFarland sold 6,500 Accendra Health shares in Q3 2022, an estimated $204K.
  • Penn Davis McFarland first reported a position in Accendra Health in Q2 2018 and held it in 15 quarters.
  • Penn Davis McFarland's Accendra Health position peaked at $388K in Q3 2018.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Penn Davis McFarland's 13F filing for Q3 2022, filed 21 Oct 2022.